Roger Wilson is a leading voice in cancer patient advocacy. He has been living with a recurrent sarcoma for 20 years, and is a co-founder of Sarcoma Patients Euronet. He is on the faculty of [more]
Patients play an integral part in the clinical trial process that enables new treatments to be approved and adopted into clinical practice. Without patients, no trials can be undertaken, and thus no drugs can be [more]
‘Value’ is the latest buzzword in cancer: value-based pricing, delivering value for cancer care, enhancing the value offering for cancer technologies… It makes sense, as focusing on the value of interventions we invest in is [more]
Precision oncology is about understanding what is driving an individual’s cancer growth, resistance and metastasis, and then targeting those pathways accordingly. Our current research models are good at developing drugs to hit targets. They are [more]
Oncology is understandably fascinated by ideas around precision treatment. As a medical oncologist who was there when the germs of this approach first appeared 50 years ago, I do of course share the excitement over [more]